Hyam Levitsky

Insider Reports History

Entity
Individual
Location
C/O Antigenics Inc., 162 Fifth Ave., Suite 900, New York, NY
Signature
/s/ Shawn Glidden, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Hyam Levitsky:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Century Therapeutics, Inc. President of R&D Common Stock 537K $2.76M $5.14 Mar 7, 2024 By Irrevocable Spousal Trust for Rhonda L. Zuckerman
Century Therapeutics, Inc. President of R&D Common Stock 24K $123K $5.14 Mar 7, 2024 Direct
Century Therapeutics, Inc. President of R&D Stock Option (right to buy) 146K Mar 7, 2024 Direct
Replimune Group, Inc. Director Stock Option (right to buy) 32K Apr 1, 2024 Direct

Insider Reports Filed by Hyam Levitsky

Symbol Company Period Transactions Value $ Form Type Date Filed Role
REPL Replimune Group, Inc. Apr 1, 2024 1 $0 4 Apr 3, 2024 Director
IPSC Century Therapeutics, Inc. Mar 7, 2024 2 $0 4 Mar 11, 2024 President of R&D
IPSC Century Therapeutics, Inc. Apr 12, 2023 1 $0 4 Apr 14, 2023 President of R&D
IPSC Century Therapeutics, Inc. Apr 12, 2023 0 $0 3 Apr 14, 2023 President of R&D
REPL Replimune Group, Inc. Apr 1, 2023 1 $0 4 Apr 4, 2023 Director
REPL Replimune Group, Inc. Apr 1, 2022 1 $0 4 Apr 5, 2022 Director
IPSC Century Therapeutics, Inc. Jan 25, 2022 1 $0 4 Jan 27, 2022 President of R&D
IPSC Century Therapeutics, Inc. Jun 17, 2021 0 $0 3 Jun 17, 2021 President of R&D